Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical silymarin gel versus placebo for pain in knee osteoarthritis
IRCT20120215009014N498Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in knee osteoarthritis (OA) comparing Silymarin + piroxicam with Placebo + piroxicam (2 arms). Primary endpoints: Pain score and Probable side effects. Started Apr 2024; status: completed.
02
Drugs
silymarin
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on IRCT20120215009014N498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N498.